Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky W Johnstone

Showing results (31-40 of 188) with videos related to

Pageof 19
Sort By:
Experimental Cell Research|May 18, 2005
The HIN-200 family: more than interferon-inducible genes?Louise E A Ludlow, Ricky W Johnstone, Christopher J P Clarke
Nature Reviews. Cancer|March 24, 2017
A chemical probe toolbox for dissecting the cancer epigenomeJake Shortt, Christopher J Ott, Ricky W Johnstone, et al.
Scientific Data|May 16, 2015
Genome-wide functional genomic and transcriptomic analyses for genes regulating sensitivity to vorinostatKatrina J Falkenberg, Cathryn M Gould, Ricky W Johnstone, et al.
Oncogene|August 2, 2003
Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescenceHong Xin, Jonathan Curry, Ricky W Johnstone, et al.
Oncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.
Cytokine & Growth Factor Reviews|October 22, 2008
IFNgamma signaling-does it mean JAK-STAT?Daniel J Gough, David E Levy, Ricky W Johnstone, et al.
Nature Reviews. Drug Discovery|September 15, 2020
Targeting the epigenetic regulation of antitumour immunitySimon J Hogg, Paul A Beavis, Mark A Dawson, et al.
Oncogene|August 11, 2005
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsEmma K Baker, Ricky W Johnstone, John R Zalcberg, et al.
Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.
Journal of Cellular Biochemistry|November 4, 2009
Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescenceChristopher J P Clarke, Linda L Hii, Jessica E Bolden, et al.
Pageof 19

Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Experimental Cell Research|May 18, 2005
The HIN-200 family: more than interferon-inducible genes?Louise E A Ludlow, Ricky W Johnstone, Christopher J P Clarke
Nature Reviews. Cancer|March 24, 2017
A chemical probe toolbox for dissecting the cancer epigenomeJake Shortt, Christopher J Ott, Ricky W Johnstone, et al.
Scientific Data|May 16, 2015
Genome-wide functional genomic and transcriptomic analyses for genes regulating sensitivity to vorinostatKatrina J Falkenberg, Cathryn M Gould, Ricky W Johnstone, et al.
Oncogene|August 2, 2003
Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescenceHong Xin, Jonathan Curry, Ricky W Johnstone, et al.
Oncoimmunology|June 28, 2012
The combination of histone deacetylase inhibitors with immune-stimulating antibodies has potent anti-cancer effectsAlison C West, Ailsa J Christiansen, Mark J Smyth, et al.
Cytokine & Growth Factor Reviews|October 22, 2008
IFNgamma signaling-does it mean JAK-STAT?Daniel J Gough, David E Levy, Ricky W Johnstone, et al.
Nature Reviews. Drug Discovery|September 15, 2020
Targeting the epigenetic regulation of antitumour immunitySimon J Hogg, Paul A Beavis, Mark A Dawson, et al.
Oncogene|August 11, 2005
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugsEmma K Baker, Ricky W Johnstone, John R Zalcberg, et al.
Oncoimmunology|December 25, 2012
Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesInge Verbrugge, Mara Galli, Mark J Smyth, et al.
Journal of Cellular Biochemistry|November 4, 2009
Inducible activation of IFI 16 results in suppression of telomerase activity, growth suppression and induction of cellular senescenceChristopher J P Clarke, Linda L Hii, Jessica E Bolden, et al.
Pageof 19